National Institute of Allergy and Infectious Diseases
Link to NIAID Home Page Link to NIAID Home Page Link to NIH Home Page
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID
 
Corner White
Print this page

Extensively Drug-Resistant Tuberculosis (XDR TB)
Diminishing Options for Treatment

Extensively Drug-Resistant TB (XDR TB)

XDR TB occurs when a Mycobacterium tuberculosis strain is resistant to isoniazid and rifampin, two of the most powerful first-line drugs, as well as key drugs of the second line regimen—any fluoroquinolone and at least one of the three injectable drugs shown above. XDR TB strains may also be resistant to additional drugs, greatly complicating therapy. Click here to see how these drugs work.

back button next button

Drug-Resistant TB—A Visual Tour

First-Line Treatment of Tuberculosis (TB) for Drug-Sensitive TB
Multidrug-Resistant Tuberculosis (MDR TB) and Possible Effective Treatments
Extensively Drug-Resistant Tuberculosis (XDR TB) Diminishing Options for Treatment
New Tuberculosis Drugs Under Development

Learn More

TB Definitions
Scientific Illustrations of Drug-Resistant TB
TB Home Page

Photo Credit: The photo of Mycobacterium tuberculosis was obtained from the Centers for Disease Control and Prevention, CDC/ Dr. Ray Butler; Janice Carr.
Illustration Credit: This illustration is in the public domain. Please credit the National Institute of Allergy and Infectious Diseases (NIAID).
Illustrator: Krista Townsend

back to top